Bryan Cranston (Your Honor) plays New Orleans Judge Michael Desiato in the Showtime limited series. He has eight previous nominations, most recently in 2016 for “All the Way.” He won one of his four consecutive bids for “Breaking Bad” in 2013. He is the lone representative from his show.
Jeff Daniels (The Comey Rule) plays FBI Director James Comey in the two-part Showtime event series. He has four previous nominations, most recently in 2012 for “The Newsroom.” His costar Brendan Gleeson is also nominated.
Hugh Grant (The Undoing) plays Dr. Jonathan Fraser in the HBO limited series. He has five previous nominations, most recently in 2018 for “A Very English Scandal.” He won on his first try back in 1994 for “Four Weddings and a Funeral.” His show is the most-nominated limited series with four total bids.
Ethan Hawke (The Good Lord Bird) plays abolitionist John Brown in the Showtime limited series. He has one previous nomination, for “Boyhood” in 2014. He is the lone representative from his show.
Mark Ruffalo (I Know This Much Is True) plays twin brothers Dominick and Thomas Birdsey in the HBO limited series. He has three previous nominations, for “Infinitely Polar Bear” in 2015 and “The Normal Heart” and “Foxcatcher” in 2014. He is the lone representative from his show.
Additional notes: Ruffalo won the Emmy this past fall, but the other four nominees here hadn’t seen their shows start by that point. Grant is the only one here whose show is up for Best Limited Series. The last nominee to play twin brothers in this category, Ewan McGregor, won this prize in 2017 for season three of “Fargo.”
Who should win? I only watched one episode of Hawke’s show, and his performance was a bit intense for me. I found Cranston’s work less than genuine and impressing. Daniels was good but wouldn’t be my choice. I think I’d choose Ruffalo over Grant, though I’m sad that Paul Mescal and Hugh Jackman aren’t here.
Who will win? It’s possible Grant gets an assist from his series’ solid showing, but I think Ruffalo wins without a problem.
No comments:
Post a Comment